Scientech Research LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

Scientech Research LLC’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,578	Closed	-$1.01M	–	828
2025 Q3	$1.01M	Buy	+2,578	New	+$1.08M	0.35%	43
2025 Q2	–	Sell	-1,635	Closed	-$793K	–	877
2025 Q1	$793K	Sell	1,635 -355	-18%	-$165K	0.21%	212
2024 Q4	$801K	Sell	1,990 -1,507	-43%	-$699K	0.23%	161
2024 Q3	$1.63M	Sell	3,497 -5,436	-61%	-$2.61M	0.32%	71
2024 Q2	$4.19M	Buy	+8,933	New	+$3.88M	0.86%	2
2024 Q1	–	Sell	-1,300	Closed	-$529K	–	593
2023 Q4	$529K	Buy	+1,300	New	+$480K	0.53%	36

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Scientech Research LLC's VRTX Position: Q4 2025 in Review

Scientech Research LLC sold out of Vertex Pharmaceuticals (VRTX) in Q4 2025, closing a stake of 2,578 shares — an estimated $1.01M sold.

Scientech Research LLC first reported a position in VRTX in Q4 2023 and held it in 6 quarters. The position peaked at $4.19M in Q2 2024. 1,668 funds tracked by Wall St. Rank hold VRTX as of Q4 2025.

Scientech Research LLC reported no remaining Vertex Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Scientech Research LLC sold 2,578 Vertex Pharmaceuticals shares in Q4 2025, an estimated $1.01M.
Scientech Research LLC first reported a position in Vertex Pharmaceuticals in Q4 2023 and held it in 6 quarters.
Scientech Research LLC's Vertex Pharmaceuticals position peaked at $4.19M in Q2 2024.
1,668 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2025.

Based on Scientech Research LLC's 13F filing for Q4 2025, filed 17 Feb 2026.